Literature DB >> 25486711

Fixing the price of the orphan drug Siklos: the Council of State takes over the decision.

Susana Murteira, Emna El Hammi, Mondher Toumi.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25486711     DOI: 10.1163/15718093-12341326

Source DB:  PubMed          Journal:  Eur J Health Law        ISSN: 0929-0273


× No keyword cloud information.
  5 in total

Review 1.  Non-profit Drug Research and Development at a Crossroads.

Authors:  Szymon Jarosławski; Mondher Toumi; Pascal Auquier; Claude Dussart
Journal:  Pharm Res       Date:  2018-02-07       Impact factor: 4.200

2.  Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats.

Authors:  Zikra Zulfiqar; Fawad Ali Shah; Shagufta Shafique; Abdullah Alattar; Tahir Ali; Arooj Mohsin Alvi; Sajid Rashid; Shupeng Li
Journal:  J Inflamm Res       Date:  2020-12-24

3.  Filling the gap in CNS drug development: evaluation of the role of drug repurposing.

Authors:  A Caban; K Pisarczyk; K Kopacz; A Kapuśniak; M Toumi; C Rémuzat; A Kornfeld
Journal:  J Mark Access Health Policy       Date:  2017-04-10

4.  Non-profit drug research and development: the case study of Genethon.

Authors:  Szymon Jarosławski; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2018-11-15

5.  [Sickle cell disease in the Democratic Republic of the Congo: what are the barriers to treatment using hydroxyurea?]

Authors:  Benoît Mbiya Mukinayi; Guelord Kalombo Cibeyibeyi; Ghislain Disashi Tumba; Béatrice Gulbis
Journal:  Pan Afr Med J       Date:  2021-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.